Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1997;28:2539-2544

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuroda, S.
Right arrow Articles by Siesjö, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuroda, S.
Right arrow Articles by Siesjö, B. K.

(Stroke. 1997;28:2539-2544.)
© 1997 American Heart Association, Inc.


Articles

The Calmodulin Antagonist Trifluoperazine in Transient Focal Brain Ischemia in Rats

Anti-ischemic Effect and Therapeutic Window

Satoshi Kuroda, MD; Akihito Nakai, MD; Tibor Kristían, PhD; Bo K. Siesjö, MD, PhD

From the Division of Experimental Brain Research, Department of Clinical Neuroscience, Wallenberg Neuroscience Center, University of Lund (Sweden) (S.K., A.N., T.K., B.K.S.); the Department of Neurosurgery, Hokkaido University School of Medicine, Sapporo, Japan (S.K.); the Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan (A.N.); and the Institute of Neurobiology, Slovak Academy of Sciences, Kosice, Slovak Republic (T.K.).

Correspondence to Satoshi Kuroda, MD, Department of Neurosurgery, Hokkaido University School of Medicine, North 15 West 7, Kita-ku, Sapporo 060, Japan.

Background and Purpose This study was performed to assess the efficacy and the therapeutic window for the calmodulin antagonist trifluoperazine in experiments involving transient middle cerebral artery (MCA) occlusion.

Methods Male Wistar rats were subjected to transient (2 hours) MCA occlusion by an intraluminal filament technique. Trifluoperazine (5.0 mg · kg-1) was injected intraperitoneally 5 minutes, 1 hour, or 2 hours after the induction of ischemia. Drug administration was repeated 24 hours after the first injection. Neurological scores and infarct volumes were evaluated at 48 hours of reperfusion. The effect of trifluoperazine on cortical blood flow was studied with continuous laser-Doppler flowmetry.

Results The median value of neurological scores in the control rats (n=7) was 3, while those in the treated groups were 1 (5-minute group; n=7, P<.05) and 2 (1-hour and 2-hour groups; each n=7). The percentage of infarct volume in the control rats was 34.8±4.9% (mean±SD), while those in the treated groups were 11.3±12.3% (5-minute group; P<.01), 24.8±15.1% (1-hour group), and 28.8±8.3% (2-hour group). Trifluoperazine, given at 5 minutes after ischemia, had no influence on blood flow in the neocortical penumbra during and after ischemia.

Conclusions The results demonstrate that trifluoperazine markedly reduces infarct volume after 2 hours of MCA occlusion when given 5 minutes after the induction of ischemia. However, the therapeutic window for trifluoperazine seems narrow since the drug had no significant effect when given after 1 or 2 hours.


Key Words: calcium • calmodulin • cerebral ischemia, focal • middle cerebral artery occlusion • rats




This article has been cited by other articles:


Home page
JEMHome page
I. G. Stavrovskaya, M. V. Narayanan, W. Zhang, B. F. Krasnikov, J. Heemskerk, S. S. Young, J. P. Blass, A. M. Brown, M. F. Beal, R. M. Friedlander, et al.
Clinically Approved Heterocyclics Act on a Mitochondrial Target and Reduce Stroke-induced Pathology
J. Exp. Med., July 19, 2004; 200(2): 211 - 222.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Yaglom, D. Ekhterae, V. L. Gabai, and M. Y. Sherman
Regulation of Necrosis of H9c2 Myogenic Cells upon Transient Energy Deprivation: RAPID DEENERGIZATION OF MITOCHONDRIA PRECEDES NECROSIS AND IS CONTROLLED BY REACTIVE OXYGEN SPECIES, STRESS KINASE JNK, HSP72, AND ARC
J. Biol. Chem., December 12, 2003; 278(50): 50483 - 50496.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Sato, Y. Morishima, and Y. Shirasaki
3-[2-[4-(3-Chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole Dihydrochloride 3.5 Hydrate (DY-9760e), a Novel Calmodulin Antagonist, Reduces Brain Edema through the Inhibition of Enhanced Blood-Brain Barrier Permeability after Transient Focal Ischemia
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1042 - 1047.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Dosemeci, T. S. Reese, J. Petersen, and J.-H. Tao-Cheng
A Novel Particulate Form of Ca2+/CaMKII-Dependent Protein Kinase II in Neurons
J. Neurosci., May 1, 2000; 20(9): 3076 - 3084.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Lipton
Ischemic Cell Death in Brain Neurons
Physiol Rev, October 1, 1999; 79(4): 1431 - 1568.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Schmid-Elsaesser, S. Zausinger, E. Hungerhuber, A. Baethmann, H.-J. Reulen, and J. H. Garcia
A Critical Reevaluation of the Intraluminal Thread Model of Focal Cerebral Ischemia : Evidence of Inadvertent Premature Reperfusion and Subarachnoid Hemorrhage in Rats by Laser-Doppler Flowmetry • Editorial Comment: Evidence of Inadvertent Premature Reperfusion and Subarachnoid Hemorrhage in Rats by Laser-Doppler Flowmetry
Stroke, October 1, 1998; 29(10): 2162 - 2170.
[Abstract] [Full Text] [PDF]